Segment Information (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Financial Data by Reportable Segment

Financial data by reportable segment for the years ended December 31, 2025, 2024 and 2023 is as follows:

			Carelon
	Health Benefits		CarelonRx		Carelon Services		Total		Corporate & Other		Eliminations		Total
Year Ended December 31, 2025
Premiums	$	159,458	$	—	$	6,315	$	6,315	$	—	$	(1,134)	$	164,639
Product revenue	—		24,470		—		24,470		—		—		24,470
Service fees	7,636		13		826		839		—		—		8,475
Operating revenue - unaffiliated	167,094		24,483		7,141		31,624		—		(1,134)		197,584
Operating revenue - affiliated	—		18,917		21,175		40,092		463		(40,555)		—
Operating revenue - total	$	167,094	$	43,400	$	28,316	$	71,716	$	463	$	(41,689)	$	197,584
Benefit expense	$	143,889	$	—	$	24,283	$	24,283	$	25	$	(19,974)	$	148,223
Cost of products sold	—		40,077		—		40,077		—		(18,899)		21,178
Operating expense	19,047		905		3,073		3,978		775		(2,816)		20,984
Operating gain (loss)	$	4,158	$	2,418	$	960	$	3,378	$	(337)	$	—	$	7,199
Year Ended December 31, 2024
Premiums	$	142,668	$	—	$	2,630	$	2,630	$	—	$	(1,132)	$	144,166
Product revenue	—		22,630		—		22,630		—		—		22,630
Service fees	7,607		5		790		795		6		—		8,408
Operating revenue - unaffiliated	150,275		22,635		3,420		26,055		6		(1,132)		175,204
Operating revenue - affiliated	—		13,326		14,541		27,867		303		(28,170)		—
Operating revenue - total	$	150,275	$	35,961	$	17,961	$	53,922	$	309	$	(29,302)	$	175,204
Benefit expense	$	126,703	$	—	$	14,388	$	14,388	$	19	$	(13,543)	$	127,567
Cost of products sold	—		32,978		—		32,978		—		(13,228)		19,750
Operating expense	17,329		811		2,856		3,667		1,560		(2,531)		20,025
Operating gain (loss)	$	6,243	$	2,172	$	717	$	2,889	$	(1,270)	$	—	$	7,862
Year Ended December 31, 2023
Premiums	$	141,515	$	—	$	1,679	$	1,679	$	—	$	(340)	$	142,854
Product revenue	—		19,452		—		19,452		—		—		19,452
Service fees	7,056		6		813		819		28		—		7,903
Operating revenue - unaffiliated	148,571		19,458		2,492		21,950		28		(340)		170,209
Operating revenue - affiliated	—		14,377		11,655		26,032		451		(26,483)		—
Operating revenue - total	$	148,571	$	33,835	$	14,147	$	47,982	$	479	$	(26,823)	$	170,209
Benefit expense	$	123,705	$	—	$	10,610	$	10,610	$	35	$	(10,020)	$	124,330
Cost of products sold	—		31,588		—		31,588		—		(14,295)		17,293
Operating expense	17,978		272		2,857		3,129		1,488		(2,508)		20,087
Operating gain (loss)	$	6,888	$	1,975	$	680	$	2,655	$	(1,044)	$	—	$	8,499

Reconciliation of Reportable Segments Operating Revenues to Total Revenues Reported in the Consolidated Statements of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the years ended December 31, 2025, 2024 and 2023 is as follows:

	2025		2024		2023
Reportable segments’ operating revenues	$	197,584	$	175,204	$	170,209
Net investment income	2,194		2,051		1,825
Net losses on financial instruments	(653)		(445)		(694)
Gain on sale of business	—		201		—
Total revenues	$	199,125	$	177,011	$	171,340

Reconciliation of Income Before Income Tax Expense to Reportable Segments Operating Gain Included in the Consolidated Statements of Income

A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the years ended December 31, 2025, 2024 and 2023 is as follows:

	2025		2024		2023
Income before income tax expense	$	6,710	$	7,904	$	7,715
Net investment income	(2,194)		(2,051)		(1,825)
Net losses on financial instruments	653		445		694
Gain on sale of business	—		(201)		—
Interest expense	1,402		1,185		1,030
Amortization of other intangible assets	628		580		885
Reportable segments’ operating gain	$	7,199	$	7,862	$	8,499